Browse Studies — Arctuva

Observational

A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating

This study is a randomized, double-blind, placebo-controlled, within-individual crossover trial designed to assess the impact of regular use of a consumer-grad…

IBS (Irritable Bowel Syndrome)BloatingAbdominal Pain+1 more

Estimated

~$10 – $8,750

Kiwi Health IncNCT07591584

Observational

A Prospective Interventional Trial With a Non-invasive Variable Compression System (VCS) to Determine the Efficacy in Patients With Moderate to Severe Irritable Bowel Syndrome (IBS)

This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowe…

IBS (Irritable Bowel Syndrome)

Estimated

~$10 – $7,500

PGP HealthNCT07540312

Phase 1

A Phase 1 Study to Evaluate the Safety of a Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea

While the pathophysiology of diarrhea-predominant irritable bowel syndrome (IBS-D) is complex and heterogeneous, dysbiosis of the gut microbiome is frequently …

IBS (Irritable Bowel Syndrome)Diarrhea

Estimated

~$10 – $6,250

Stanford UniversityNCT07238790

Phase 2

A Phase 2b, Randomized, Double-Blind, Placebo- Controlled, Multicenter Study to Assess the Safety, Efficacy and Pharmacokinetics of RNIB21 in the Treatment of Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)

The purpose of this study is to examine the effectiveness of using a combination of a drug, rifaximin and a dietary supplement, N-acetyl-L-cysteine (NAC), to t…

IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)

Estimated

~$10 – $7,500

Mark Pimentel, MDNCT06727422